Ads
related to: pharmaceutical industry trends
Search results
Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth By Investing.com
Investing.com· 5 days agoIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD) provided an update on its financial and operational...
2 Instruments Stocks to Watch From a Prospering Industry
Zacks via Yahoo Finance· 1 day agoThe Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR)...
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
Zacks via Yahoo Finance· 2 days agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
Zacks· 16 hours ago(MTD Quick QuoteMTD - Free Report) and Bruker (BRKR Quick QuoteBRKR - Free Report) . The Zacks Instruments - Scientific industry is benefiting from increasing healthcare spending ...
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 7 days agoFree Report) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of $0.24. This quarterly report represents an earnings surprise of -291.67%. Over the last ...
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 2 days agoJohnson & Johnson (JNJ Quick QuoteJNJ - Free Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals industry& ...
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Zacks· 7 days agoFree Report) came out with quarterly earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.49 per share. This quarterly report represents an earnings surprise of -2.68%. A ...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 1 day agoOver 100 years of market history reveals that the stocks that go on to make the biggest gains tend...
Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024
BioPharma-Reporter· 8 hours agoBPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we...
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
Zacks· 7 days agoFree Report) came out with a quarterly loss of $0.93 per share versus the Zacks Consensus Estimate of a loss of $0.84. This quarterly report represents an earnings surprise of -10.71%. Over ...
